Journal of Urban Health

, Volume 77, Issue 1, pp 113–120 | Cite as

Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices

  • Colin R. Harbke
  • Dennis G. FisherEmail author
  • Henry H. Cagle
  • Beth N. Trubatch
  • Andrea M. Fenaughty
  • Mark E. Johnson
Original Articles: Various Topics



To determine the availability of nonprescription needles and syringes (NS) through pharmacy sales and to assess the impact of pharmacy policies and municipal paraphernalia laws on pharmacists' selling practices.


Telephone survey of all pharmacies in Alaska's four largest cities.


Anchorage, Fairbanks, Juneau, and Ketchikan, Alaska.


A single pharmacist from each pharmacy represented in the cities' phone books.

Main Outcome Measures

Reports of (1) pharmacies' policies and individual pharmacists' procedures regarding the nonprescription sale of NS, (2) pharmacists' selling practices, and (3) identification of conditions that may affect pharmacists' decisions to sell nonprescription NS.


Response rate of 86% (37/43); 77% of pharmacists reported selling at least one nonprescription NS in the last month. Store policy was related to selling practices; however, there was no difference in selling practices between a city with a paraphernalia law and cities without such laws. Logistic regression revealed pharmacists were more likely to sell NS if they worked in chain pharmacies and estimated that a high number of other local pharmacists sell nonprescription NS.


NS are available through nonprescription sales in Alaskan pharmacies. The majority of pharmacies have store policies that permit pharmacists to sell nonprescription NS, either in all cases or at their discretion. Municipal paraphernalia laws do not determine the selling practices of individual pharmacists.


Public Health Logistic Regression Large City Telephone Survey Main Outcome Measure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shah S, Shapshak P, Rivers JE et al., Detection of HIV-1 DNA in needles/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:301–306.PubMedGoogle Scholar
  2. 2.
    Koester S. Following the blood: syringe reuse leads to blood-borne virus transmission among injection drug users [letter].J Acquir Immune Defic Syndr Hum Retrovirol 1998 July;18(suppl 1):139.Google Scholar
  3. 3.
    National Research Council and Institute of Medicine.Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Normand J, Vlahov D, Moses LE, editors. Washington, DC: National Academy Press; 1995.Google Scholar
  4. 4.
    Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users.JAMA. 1997;277:53–62.PubMedGoogle Scholar
  5. 5.
    Gleghorn AA, Gee G, Vlahov D. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.J Acquir Immune Defic Syndr Hum Retrovirol. 1998 July;18(suppl 1):89–93.Google Scholar
  6. 6.
    Gleghorn AA, Jones TS, Doherty MC, Celentano DD, Vlahov D. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland.J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:97–103.PubMedGoogle Scholar
  7. 7.
    Sheridan J, Strang J, Barber N, Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales.BMJ. 1996;313:272–274.PubMedGoogle Scholar
  8. 8.
    Glanz A, Byrne C, Jackson P. Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales.BMJ. 1989; 299:1076–1079.PubMedGoogle Scholar
  9. 9.
    Case P, Beckett GA, Jones TS. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.J Acquir Immune Defic Syndr Hum Retrovirol 1998 July;18(suppl 1):94–101.Google Scholar
  10. 10.
    Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales—Connecticut, 1992–1993.J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:73–81.PubMedGoogle Scholar
  11. 11.
    Wright-De Aguero L, Weinstein B, Jones TS, Miles J. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.J Acquir Immune Defic Syndr Hum Retrovirol 1998 July;18(suppl 1):102–110.Google Scholar
  12. 12.
    Lurie P, Wolfe SM. Letter to Harold Varmus.Public Citizen Health Res Group. 1996:2–5.Google Scholar
  13. 13.
    Fenaughty AM, Cagle HH, Fisher DG, Reynolds GL. Alaskan drug users' use of pharmacies for purchasing needles. Paper presented at:APHA 126th Annual Meeting and Exhibition. November 15–18, 1998. Washington, DC.Google Scholar
  14. 14.
    Cagle HH, Fisher DG, Queen PJ, Des Jarlais DC. Patterns of needle procurement in Anchorage, Alaska. Paper presented at:10 th International Conference on AIDS. August 7–12, 1996. Yokohama, Japan.Google Scholar

Copyright information

© The New York academy of medicine 2000

Authors and Affiliations

  • Colin R. Harbke
    • 1
  • Dennis G. Fisher
    • 1
    Email author
  • Henry H. Cagle
    • 1
  • Beth N. Trubatch
    • 1
  • Andrea M. Fenaughty
    • 1
  • Mark E. Johnson
    • 1
  1. 1.IVDU ProjectUniversity of Alaska AnchorageAnchorage

Personalised recommendations